This expert commentary reviews key clinical advances presented at the 2026 ASCO Annual Meeting that may influence the management of nonsmallcell and small cell lung cancers Faculty discuss the findings from LIBRETTO432 WUKONG28 HAROMNi6 CROWN and FLAME trials and IMforte and DELLphi304 posthoc analyses Readers will examine the phase III findings such as ivonescimab a bispecific antibody targeting PD1 and VEGF in advanced NSCLC and a variety of kinase inhibitors like selpercatinib for RET fusionpositive NSCLC sunvozertinib for EGFR exon 20 insertion NSCLC a 7year followup of lorlatinib for ALKpositive NSCLC and a phase II treatment escalation study of osimertinib plus chemotherapy for persistent EGFRmutated NSCLC Readers will also find new clinical data on FDAapproved therapies through several post hoc analyses such as the intracranial efficacy of tarlatamab in extensivestage SCLC and transcriptomic and qualityoflife analyses of maintenance lurbinectedin plus atezolizumab in extensivestage SCLC
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Drive
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Recorded-from-live session
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJul 31, 2026
-
Last day to claim creditJan 31, 2028 1 year left
-
PRIME Education, Inc. (PRIME®) Evolving Treatment Strategies in ES-SCLC: From Emerging Evidence to Patient Care
-
Answers in CME Inc. (AiCME) Navigating ADC Therapy in Lung Cancer: An APP Guide to Selection, Safety, and Care Coordination
-
American Society of Clinical Oncology One Patient, Many Pathways: Management Options in ALK-Positive Non Small Cell Lung Cancer From Early Stage to Advanced Disease – 2026 ASCO Annual Meeting
-
Clinical Care Options, LLC (dba Decera Clinical Education) Gastrointestinal Cancer Highlights From ASCO 2026: Expert Perspectives on Emerging Practice-Changing Data
-
Clinical Care Options, LLC (dba Decera Clinical Education) What s Next in SCLC: Expert Perspectives on Practice-Changing Updates From 2025 Global Congresses
-
Clinical Care Options, LLC (dba Decera Clinical Education) Decoding Discoveries in Hematologic Malignancies Decera Clinical Education’s Independent Highlights of the 2026 ASCO and EHA Conferences
